Scientists for the Food and Drug Administration said Friday a pill to treat obesity from Orexigen Therapeutics Inc. helped patients lose weight, though it didnt meet all the criteria set forth by the agency. The FDAs review also raised questions about the pills effects on the heart, a perennial issue for weight loss drugs that have been plagued by safety issues.